Oragenics Inc
NYSE: OGEN
- Raised $850,000 (2023)
- 3 clinical trials, 1 active
- Research grants: $713,308
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
SQZ Biotechnologies Co
- Raised $66 million (2020)
- 3 clinical trials
- Research grants: $10 million
- Founded 2013
Oncternal Therapeutics, Inc.
- Raised $6.5 million (2020)
- 5 clinical trials
- Research grants: $8.4 million
- Founded 2013
Ultragenyx Pharmaceutical Inc.
Nasdaq: RARE
- Raised $75 million (2012)
- 62 clinical trials, 18 active
- 3 FDA-registered drug sites
- Founded 2011
Visby Medical, Inc.
- Raised $109 million (2022)
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $3.8 million
Elucid Bioimaging Inc.
- Raised $36 million (2025)
- 5 clinical trials
- FDA-cleared or approved devices
- Research grants: $8.3 million
Tissuetech, Inc.
- Raised $55 million (2019)
- 15 clinical trials
- FDA-cleared or approved devices
- Research grants: $8.4 million
Clear Guide Medical, Inc.
- Raised $1.2 million (2016)
- 9 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $15 million
Viatris Inc
Nasdaq: VTRS
- 221 clinical trials, 3 active
- FDA-cleared or approved devices
- 7 FDA-registered drug sites
Ocular Therapeutix, Inc
Nasdaq: OCUL
- Raised $38 million (2019)
- 33 clinical trials, 4 active
- 1 FDA-registered drug site
- Founded 2006
ELI LILLY & Co
NYSE: LLY
- 2325 clinical trials, 248 active
- FDA-cleared or approved devices
- 6 FDA-registered drug sites
Penumbra Inc
NYSE: PEN
- Raised $121,230 (2012)
- 33 clinical trials, 5 active
- FDA-cleared or approved devices
CoapTech, Inc.
- Raised $7.1 million (2024)
- 4 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $7.6 million
Dexcom Inc
Nasdaq: DXCM
- Raised $7.2 million (2016)
- 38 clinical trials, 6 active
- FDA-cleared or approved devices
Bright Uro, Inc.
- Raised $15 million (2025)
- 5 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $4.1 million
Ceribell, Inc.
Nasdaq: CBLL
- Raised $103 million (2022)
- 4 clinical trials, 3 active
- FDA-cleared or approved devices
Xeris Pharmaceuticals Inc
- Raised $30 million (2017)
- 15 clinical trials
- Research grants: $14 million
Nuvasive Inc
- Raised $40 million (2011)
- 38 clinical trials, 9 active
- FDA-cleared or approved devices
iRhythm Holdings, Inc.
Nasdaq: IRTC
- Raised $27 million (2015)
- 4 clinical trials
- FDA-cleared or approved devices
- Founded 2006
Actinium Pharmaceuticals, Inc.
NYSE: ATNM
- Raised $6.6 million (2014)
- 6 clinical trials, 2 active
- Research grants: $4.2 million
PhaseBio Pharmaceuticals Inc
- Raised $26 million (2018)
- 13 clinical trials
- Research grants: $6.4 million
Sarepta Therapeutics, Inc.
Nasdaq: SRPT
- Raised $400 million (2020)
- 53 clinical trials, 14 active
- 1 FDA-registered drug site
Cel Sci Corp
NYSE: CVM
- Raised $78,000 (2018)
- 2 clinical trials
- Research grants: $4.1 million
iotaMotion, Inc.
- Raised $1.9 million (2026)
- 4 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $8 million
Exact Sciences Corp
Nasdaq: EXAS
- Raised $8.2 million (2009)
- 32 clinical trials, 7 active
- FDA-cleared or approved devices
Cytovale Inc.
- Raised $16 million (2022)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $4.3 million
Civatech Oncology, Inc.
- Raised $7.9 million (2021)
- 6 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $20 million
Kiniksa Pharmaceuticals International, plc
Nasdaq: KNSA
- Raised $8.8 million (2020)
- 14 clinical trials, 5 active
- Founded 2015
Silence Therapeutics plc
Nasdaq: SLN
- Raised $45 million (2021)
- 8 clinical trials, 1 active
- Founded 1994
ReShape Weightloss Inc.
- Raised $2.8 million (2018)
- 10 clinical trials
- Research grants: $2.6 million
Oculogica, Inc.
- Raised $7.6 million (2024)
- 6 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $1.1 million
MediBeacon Inc.
- Raised $16 million (2025)
- 12 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $363,008
Imbed Biosciences, Inc
- Raised $3.5 million (2023)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $7.2 million
Abcuro, Inc.
- Raised $80 million (2025)
- 4 clinical trials, 1 active
- Research grants: $590,634
- Founded 2015
CytomX Therapeutics, Inc.
Nasdaq: CTMX
- Raised $30 million (2023)
- 9 clinical trials, 2 active
- Research grants: $468,956
- Founded 2010
Elutia Inc.
Nasdaq: ELUT
- Raised $11 million (2023)
- 14 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2015
Materna Medical Inc
- Raised $11 million (2025)
- 4 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $4.3 million
Beyond Air, Inc.
Nasdaq: XAIR
- Raised $21 million (2024)
- 10 clinical trials
- FDA-cleared or approved devices
- Founded 2015
Illumina, Inc.
Nasdaq: ILMN
- 17 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $8.9 million
Align Technology Inc
Nasdaq: ALGN
- Raised $72 million (2009)
- 6 clinical trials, 2 active
- FDA-cleared or approved devices
IceCure Medical Ltd.
Nasdaq: ICCM
- Raised $17 million (2026)
- 6 clinical trials, 2 active
- FDA-cleared or approved devices
Repligen Corp
Nasdaq: RGEN
- Raised $48 million (2019)
- 6 clinical trials
- Research grants: $1.2 million
TriSalus Life Sciences, Inc.
Nasdaq: TLSI
- Raised $22 million (2025)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2010
Lucira Health, Inc.
- Raised $33 million (2020)
- 3 clinical trials
- Research grants: $12 million
CapsoVision, Inc
Nasdaq: CV
- Raised $65 million (2024)
- 7 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2005
Xencor Inc
Nasdaq: XNCR
- Raised $25 million (2021)
- 30 clinical trials, 8 active
- Research grants: $199,000
- Founded 2004
Peca Labs, Inc.
- Raised $2.7 million (2025)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
- Research grants: $2.9 million
Acadia Pharmaceuticals Inc
Nasdaq: ACAD
- Raised $86 million (2013)
- 41 clinical trials, 6 active
- Research grants: $1.6 million
Merck & Co., Inc.
NYSE: MRK
- 2546 clinical trials, 348 active
- 1 FDA-registered device site
- 8 FDA-registered drug sites
Virtuoso Surgical, Inc.
- Raised $2.9 million (2026)
- 1 clinical trial, 1 active
- Research grants: $11 million
- Founded 2016
Published company profiles only; counts update daily. Data licences